Replies to post #16586 on Algernon Pharmaceuticals Inc (AGNPF)

[McMagyar]

Why wouldn’t you do no psych dose to grow neurons?
I think dementia patients will be talking this treatment .

The bigger factor is

many Canadian companies treat
their companies like club Canada..
They make sure Canadians win
and really everyone else is a second class.

I get that for protecting ownership in Canadian hands.. us should do a better job.

Personally I would like to see
a forward plan..
Of what happens WHEN we are successful?

Do we get dividends?
We own 60% of algernon Neuro but what does that mean?

I think this is a winner..
but have seen winners be losers for
common shareholders and not leadership..

So I love the product
Love the opportunity
Like Chris and his leadership..
Could absolutely go much deeper investment wise if I understood

How all investors will win when this becomes a blockbuster drug..

Why wouldn’t the neuroscience people just invest in algernon?

Is algernon going to dividend the 60% of neuroscience to shareholders?


Holding companies May languish for very long periods of time